Analyzing Randomized Dose Finding Studies with a Primary and a Secondary Endpoint
From MaRDI portal
Publication:4803389
DOI10.1081/BIP-120019273zbMATH Open1181.62180OpenAlexW1987386643WikidataQ73348132 ScholiaQ73348132MaRDI QIDQ4803389FDOQ4803389
Authors: Ludwig A. Hothorn, Gernot Wassmer
Publication date: 2 April 2003
Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1081/bip-120019273
Recommendations
- A dose finding procedure based on the multivariate likelihood ratio test
- Simultaneous identifications of the minimum effective dose in each of several groups
- NONPARAMETRIC IDENTIFICATION OF THE MINIMUM EFFECTIVE DOSE FOR RANDOMIZED BLOCK DESIGNS
- Multiple testing for dose finding
- Nonparametric Multiple Test Procedures for Dose Finding
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Cites Work
Cited In (4)
- Protocol Designed Subgroup Analyses in Multiarmed Clinical Trials: Multiplicity Aspects
- A Cautionary Note on Design Implications when the Primary Analysis is a Stratified Analysis of a Binary Endpoint
- Two‐Stage Designs for Dose‐Finding Trials with a Biologic Endpoint Using Stepwise Tests
- Retrospective Analysis of Sequential Dose‐Finding Designs
This page was built for publication: Analyzing Randomized Dose Finding Studies with a Primary and a Secondary Endpoint
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4803389)